Cargando…
Comparative aspects of mast cell neoplasia in animals and the role of KIT in prognosis and treatment
Mast cell neoplasia clinical presentation and biological behaviour vary considerably across mammalian species, ranging from a solitary benign mass to an aggressive systemic malignancy. Mutations in the KIT Proto‐Oncogene Receptor Tyrosine Kinase (KIT) gene are common molecular abnormalities involved...
Autores principales: | Tamlin, Vanessa S., Bottema, Cynthia D. K., Peaston, Anne E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036313/ https://www.ncbi.nlm.nih.gov/pubmed/31650704 http://dx.doi.org/10.1002/vms3.201 |
Ejemplares similares
-
Canine mast cell tumours part I: Clinical and survival outcomes
por: Tamlin, Vanessa S., et al.
Publicado: (2022) -
Comparative Aspects of Rat and Human Hepatocellular Preneoplasia and
Neoplasia
por: Bannasch, Peter
Publicado: (2013) -
Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive
por: Joris, Magalie, et al.
Publicado: (2012) -
Mast cells rescue implantation defects caused by c-kit deficiency
por: Woidacki, K, et al.
Publicado: (2013) -
Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling
por: Roy, Lopamudra Das, et al.
Publicado: (2013)